Quality of life assessment following peptide receptor radionuclide therapy (PRRT) of pancreatic neuroendocrine tumor (P-NET)

被引：0
|
作者：
Marinova, Milka [3 ]
Muecke, Martin [1 ]
Mahlberg, Lukas [2 ]
Essler, Markus [2 ]
Cuhls, Henning [1 ]
Radbruch, Lukas [1 ]
Ahmadzadehfar, Hojjat [2 ]
机构：
[1] Univ Hosp Bonn, Bonn, Germany
[2] Univ Hosp Bonn, Nucl Med, Bonn, Germany
[3] Univ Hosp Bonn, Radiol, Bonn, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1462
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Clonal Hematopoiesis in Patients with Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy (PRRT)
    Singh, Abhay
    Gravina, Matthew
    Tajammal, Rutaba
    Nowak, Annmarie
    Iyer, Renuka
    Faber, Mark G.
    Yan, LunBiao
    Hassane, Duane C.
    Guzman, Monica L.
    Mencia-Trinchant, Nuria
    Wang, Eunice S.
    Thota, Swapna
    BLOOD, 2020, 136
  • [42] Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors: current state and future perspectives
    Baum, Richard P.
    Puranik, Ameya D.
    Kulkarni, Harshad R.
    INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2015, 2 (02) : 151 - 158
  • [43] Toxicity identification and evaluation of peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NETs)
    Duan, Heying
    Girod, Bradley
    Ninatti, Gaia
    Ferri, Valentina
    Kunz, Pamela
    Fisher, George
    Moradi, Farshad
    Davidzon, Guido
    Franc, Benjamin
    Iagaru, Andrei
    Aparici, Carina Mari
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [44] A Clinical Score (CS) for Well-Differentiated Neuroendocrine Tumor (WD-NET) Patients (Pts) Undergoing Peptide Receptor Radionuclide Therapy (PRRT)
    Das, S.
    Du, L.
    Schad, A.
    Jain, S.
    Jessop, A.
    Shah, C.
    Eisner, D.
    Cardin, D.
    Ciombor, K.
    Goff, L.
    Bradshaw, M.
    Delbeke, D.
    Sandler, M.
    Berlin, J.
    PANCREAS, 2021, 50 (03) : 452 - 452
  • [45] Surgery, Liver Directed Therapy and Peptide Receptor Radionuclide Therapy for Pancreatic Neuroendocrine Tumor Liver Metastases
    Ngongoni, Rejoice
    Visser, Brendan
    CANCERS, 2022, 14 (20)
  • [46] Partial Response Upon Peptide Receptor Radionuclide Therapy in a Highly Proliferative Pancreatic Neuroendocrine Tumor
    Weich, Alexander
    Serfling, Sebastian E.
    Rowe, Steven P.
    Solnes, Lilja B.
    Buck, Andreas K.
    Higuchi, Takahiro
    Werner, Rudolf A.
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (06) : 547 - 548
  • [47] Evaluation of interim Dotatate-PET after two cycles of Peptide Receptor Radionuclide Therapy (PRRT) in neuroendocrine tumors (NET)
    Duan, H.
    Song, H.
    Ferri, V
    Fisher, G.
    Shaheen, S.
    Shah, J.
    Nguyen, J.
    Moradi, F.
    Davidzon, G.
    Franc, B.
    Iagaru, A.
    Mari, Aparici C.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 141 - 141
  • [48] Safety and efficacy of 177Lu DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) in progressive gastro-entero-pancreatic (GEP) Neuroendocrine Tumour (NET)
    Alipour, R.
    Karri, R. K.
    Boehm, E.
    Jewell, K.
    Fahey, M.
    Saghebi, J.
    Cardin, A.
    Neeson, L.
    Buteau, J. P.
    Kumar, A. Ravi
    Akhurst, T.
    Hofman, M.
    Michael, M.
    Hicks, R.
    Kong, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S665 - S666
  • [49] Utility of midpoint imaging in patients receiving peptide receptor radionuclide therapy (PRRT) for advanced progressive midgut neuroendocrine tumors (NET)
    Norman, A.
    Wee, C.
    Hobday, T.
    Kendi, A.
    Johnson, G.
    Thorpe, M.
    Lunn, B.
    Bach, C.
    Eiring, R.
    Halfdanarson, T.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 192 - 192
  • [50] Quality Of Life in Patients with Neuroendocrine Gastroenteropancreatic Tumors Treated with Peptide Receptor Radionuclide Therapy
    Georgakopoulos, A.
    Liotsou, T.
    Chatziioannou, S. N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S691 - S691
12345